Clinical Trial Update: Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating CM310 for uncontrolled seasonal allergic rhinitis is currently recruiting at Beijing Tongren Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• CM310

Snippet

Sponsor: Beijing Tongren Hospital | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: RECRUITING